Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells.

E A Rupp; P M Cameron; C S Ranawat; J A Schmidt; E K Bayne

doi:10.1172/JCI112649

Find articles by Rupp, E. in: PubMed | Google Scholar

Find articles by Cameron, P. in: PubMed | Google Scholar

Find articles by Ranawat, C. in: PubMed | Google Scholar

Find articles by Schmidt, J. in: PubMed | Google Scholar

Find articles by Bayne, E. in: PubMed | Google Scholar

Published in Volume 78, Issue 3 on September 1, 1986
J Clin Invest. 1986;78(3):836–839. https://doi.org/10.1172/JCI112649.
© 1986 The American Society for Clinical Investigation

Published September 1, 1986 - Version history

In this report we compare the bioactivities of pure, human monocyte-derived interleukin 1 (IL-1) alpha and beta in the standard murine thymocyte proliferation assay, a human dermal fibroblast proliferation assay, and in an assay measuring stimulation of prostaglandin E2 (PGE2) release from human rheumatoid synoviocytes. In each case the different species of IL-1 produced saturable stimulation and gave similar dose response curves. Half-maximal stimulation was observed at average IL-1 concentrations of 29 pM in the thymocyte assay, 2 pM in the dermal fibroblast proliferation assay, and 5 pM in the synovial cell assay. Our results show that native, monocyte-derived IL-1 alpha and IL-1 beta are both potent stimulators of connective tissue cells and that the specific bioactivities of these molecules are similar to each other in tests on human connective tissue cells, as well as on murine lymphoid cells.

Click on an image below to see the page. View PDF of the complete article